No mention. I wonder if it will ever be mentioned because it's use.
If you read below it doesn't mention any druf under 'Sales of Cataract & Vitrectomy'
Surgical sales rose 20.2 percent or 12.0 percent on a constant
currency basis, to $697.9 million. Sales of intraocular lenses
increased 23.6 percent to $260.9 million, primarily driven by
the global increase in sales of the AcrySof(R) IQ aspheric
intraocular lens and a 71.6 percent increase in sales of the
company's advanced technology intraocular lenses, AcrySof(R)
ReSTOR(R) Aspheric and AcrySof(R) Toric. Sales of advanced
technology intraocular lenses were $47.6 million, which
represented 18.2 percent of overall dollar sales of
intraocular lenses. Sales of cataract and vitrectomy products
rose 13.4 percent, due to continued market share gains and
conversion to advanced technology. Refractive revenue
increased 160.8 percent due to revenues generated by WaveLight
AG, offset by declines in procedure revenue generated from the
installed base of LADAR(R) excimer lasers.
- Forums
- ASX - By Stock
- no mention from alcon
AOS
advanced ocular systems limited
No mention. I wonder if it will ever be mentioned because it's...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)